Next 15 drugs chosen for Medicare negotiation

Medicare targets popular weight loss drugs Ozempic, Wegovy for price negotiations
The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, diabetes and asthma.
Medicare announces 15 new drugs up for price negotiations, including Ozempic
The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, which includes Ozempic.
15 Costly Medicare Drugs Selected for Next Round of Price Negotiations
Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations for 10 drugs whose lower prices take effect in 2026. T
Ozempic, Wegovy and other drugs are among 15 selected for Medicare’s price negotiations
The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers.
Medicare drug price negotiations to target Ozempic, Wegovy and other drugs
Medicare announced Friday that it has selected 15 drugs, including the hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, as well as some blockbuster cancer medications and other drugs, for its second round of price talks.
Latest Medicare price drug negotiations includes Ozempic, Wegovy
Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in lower prices for patients, the Department of Health and Human Services confirmed Friday.
Medicare to Negotiate Lower Prices for Weight-Loss Drugs
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.
Medicare to negotiate price of Ozempic, Wegovy weight-loss drugs
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
Ozempic among drugs selected for Medicare price negotiations as Biden exits
Ozempic was one of the 15 drugs selected for the 2027 Medicare drug price negotiation program three days before President-elect Donald Trump takes office.
The next 15 drugs chosen for Medicare negotiation
The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts before the inauguration of President-elect Trump. The Centers for Medicare and Medicaid Services (CMS) had until Feb.
Biden administration adds 15 drugs to Medicare price negotiation list
Medicare enrollees, however, still won’t be able to access the drugs for obesity under a federal law that prohibits the program from paying for weight loss treatments. Right now
Ozempic and Wegovy selected for next round of Medicare drug price negotiations
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...
wtvr1h
Active Medicare Solutions - a full-service medicare company
Watch Virginia This Morning each weekday from 9 to 10 a.m. Find the show on Facebook and Instagram at @VirginiaThisMorning.
Trump set to break the all-time federal debt record amid inflation battle
Federal debt BX:TMUBMUSD10Y held by the public as a share of the total economy will surpass the previous record of 106.1%, set in the waning days of World War II, by 2029, Trump's last year in office.
Money Talks News on MSN1h
The Medicare Myth: Why Your Health Coverage May Fall Short
Think Medicare covers all your healthcare needs in retirement? Think again. TikTok ban upheld by Supreme Court days before ...
Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today
A shake-up may be brewing in the market for GLP-1 diet drugs Friday, and it's making itself felt all across the field of ...
JD Supra2h
EnforceMintz — FCA Enforcement in Value-Based Care Arrangements Heated Up in 2024 and Likely to Remain a Priority in 2025
Value-based care (VBC) is a health care delivery model that has grown increasingly common in recent years. Perhaps ...
CBO projects U.S. debt to grow $23.9 trillion in 10 years, not including costs of extending tax cuts
The national debt is slated to rise by $23.9 trillion over the next decade, a sum that does not include trillions of dollars ...